GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivozon Pharmaceutical Co Ltd (XKRX:082800) » Definitions » Cyclically Adjusted FCF per Share

Vivozon Pharmaceutical Co (XKRX:082800) Cyclically Adjusted FCF per Share : ₩-386.52 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Vivozon Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Vivozon Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩-87.980. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩-386.52 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -30.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 27.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Vivozon Pharmaceutical Co was 56.50% per year. The lowest was -30.50% per year. And the median was 36.40% per year.

As of today (2024-06-05), Vivozon Pharmaceutical Co's current stock price is ₩3415.00. Vivozon Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩-386.52. Vivozon Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is .


Vivozon Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Vivozon Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivozon Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Vivozon Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,254.61 -179.25 -261.84 -322.97 -398.25

Vivozon Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -367.17 -356.76 -251.85 -398.25 -386.52

Competitive Comparison of Vivozon Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vivozon Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivozon Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivozon Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vivozon Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Vivozon Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vivozon Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-87.98/118.8477*118.8477
=-87.980

Current CPI (Mar. 2024) = 118.8477.

Vivozon Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -96.078 99.353 -114.930
201409 389.815 99.608 465.109
201412 -431.214 99.098 -517.153
201503 -77.849 99.720 -92.782
201506 -155.225 100.050 -184.389
201509 274.566 100.110 325.957
201512 57.126 100.220 67.744
201603 -286.181 100.560 -338.225
201606 354.193 100.790 417.651
201609 108.088 101.460 126.612
201612 296.339 101.560 346.782
201703 -167.791 102.850 -193.890
201706 44.287 102.610 51.295
201709 -261.743 103.490 -300.585
201712 133.804 102.990 154.406
201803 -436.142 104.100 -497.930
201806 82.915 104.130 94.634
201809 -2,042.899 105.650 -2,298.096
201812 976.687 104.350 1,112.381
201903 -3,003.326 104.490 -3,416.005
201906 1,663.787 104.880 1,885.367
201909 191.409 105.200 216.241
201912 517.523 105.120 585.107
202003 -28.303 105.540 -31.872
202006 1.166 104.870 1.321
202009 29.578 106.200 33.101
202012 121.135 105.765 136.118
202103 -266.551 107.357 -295.080
202106 -305.667 107.579 -337.686
202109 -156.020 108.759 -170.492
202112 -179.691 109.676 -194.717
202203 -55.250 111.806 -58.730
202206 -100.599 114.083 -104.801
202209 -65.611 114.831 -67.906
202212 -55.984 115.200 -57.757
202303 -485.893 116.550 -495.474
202306 -0.133 117.140 -0.135
202309 -1.316 119.111 -1.313
202312 -27.138 118.848 -27.138
202403 -87.980 118.848 -87.980

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Vivozon Pharmaceutical Co  (XKRX:082800) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Vivozon Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Vivozon Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivozon Pharmaceutical Co (XKRX:082800) Business Description

Traded in Other Exchanges
N/A
Address
Yongin Techno Valley, 9th and 10th Floor, Building D, Guseong-ro 357, Giheung-gu, Gyeonggi-do, Yongin-si, KOR
Vivozon Pharmaceutical Co Ltd is a global innovative drug development company.

Vivozon Pharmaceutical Co (XKRX:082800) Headlines

No Headlines